Acrux Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
25,775.00
23,068.00
29,360.00
33,974.00
28,470.00
Total Accounts Receivable
5,488.00
4,826.00
4,710.00
5,532.00
312.00
Other Current Assets
116.00
117.00
73.00
91.00
179.00
Total Current Assets
31,379.00
28,011.00
34,143.00
39,597.00
28,961.00
Net Property, Plant & Equipment
78.00
92.00
262.00
778.00
845.00
Intangible Assets
21,764.00
20,392.00
18,966.00
6,839.00
803.00
Total Assets
54,288.00
49,659.00
55,019.00
49,416.00
32,490.00
Accounts Payable
217.00
106.00
606.00
564.00
731.00
Income Tax Payable
4,526.00
1,764.00
3,503.00
1,136.00
-
Other Current Liabilities
1,313.00
1,332.00
1,629.00
1,662.00
1,753.00
Total Current Liabilities
6,056.00
3,202.00
5,738.00
3,362.00
2,484.00
Provision for Risks & Charges
11.00
19.00
17.00
19.00
35.00
Deferred Taxes
5,097.00
4,649.00
3,727.00
92.00
1,881.00
Total Liabilities
12,231.00
9,034.00
11,130.00
5,491.00
2,519.00
Common Equity (Total)
42,057.00
40,625.00
43,889.00
43,925.00
29,971.00
Total Shareholders' Equity
42,057.00
40,625.00
43,889.00
43,925.00
29,971.00
Total Equity
42,057.00
40,625.00
43,889.00
43,925.00
29,971.00
Liabilities & Shareholders' Equity
54,288.00
49,659.00
55,019.00
49,416.00
32,490.00

About Acrux

View Profile
Address
103-113 Stanley Street
West Melbourne Victoria (VIC) 3003
Australia
Employees -
Website http://www.acrux.com.au
Updated 07/08/2019
Acrux Ltd. operates as a pooled development fund that invests in pharmaceutical businesses. The firm develops and commercializes pharmaceutical products using unique technology to administer drugs through the skin. It operates through the following geographical segments: Australia, Switzerland, United States, and Other.